PDZK1, an oestrogen-responsive gene associated with good prognosis showed differential expression between ER positive and negative tumour cell lines, confirmed by IHC and PDZK1 protein expression was associated with improved breast-cancer-specific survival, ER positivity and low-tumour grade. This evidence concerns the gene EREG and breast carcinoma.